Evidence map›Paper›PMID 29454881›Full record

ArticleBrain, behavior, and immunity2018

Curcumin treatment leads to better cognitive and mood function in a model of Gulf War Illness with enhanced neurogenesis, and alleviation of inflammation and mitochondrial dysfunction in the hippocampus.

M Kodali, B Hattiangady, G A Shetty, A Bates, B Shuai, A K Shetty

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Curcumin (International journal of environmental research and public health · 2021
    Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. FDA-approved cannabidiol [EpidiolexMilitary Medical Research · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M KodaliOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA.
B HattiangadyOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA.
G A ShettyOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA.
A BatesOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA.
B ShuaiOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA.
A K ShettyOlin E. Teague Veterans' Medical Center, Central Texas Veterans Health Care System, Temple, TX, USA; Institute for Regenerative Medicine, Texas A&M Health Science Center College of Medicine, Temple and College Station, TX, USA; Department of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, TX, USA. Electronic address: shetty@medicine.tamhsc.edu.
Texas A&M Health Science Center · USOlin E. Teague Veterans Medical Center · USTemple College · US

Funding

Memory and Mood Enhancing Therapies for Gulf War IllnessI01BX000883 · VA · OLIN TEAGUE VETERANS CENTER · PI SHETTY, ASHOK K · 2011 to 2015
–
BLR&D Research Career Scientist AwardIK6BX003612 · VA · OLIN TEAGUE VETERANS CENTER · PI SHETTY, ASHOK K · 2017 to 2019
–
BLRD VA I01 BX000883BLRD VA IK6 BX003612
6 · The paper itself

Abstract

Diminished cognitive and mood function are among the most conspicuous symptoms of Gulf War Illness (GWI). Our previous studies in a rat model of GWI have demonstrated that persistent cognitive and mood impairments are associated with substantially declined neurogenesis, chronic low-grade inflammation, increased oxidative stress and mitochondrial dysfunction in the hippocampus. We tested the efficacy of curcumin (CUR) to maintain better cognitive and mood function in a rat model of GWI because of its neurogenic, antiinflammatory, antioxidant, and memory and mood enhancing properties. Male rats were exposed daily to low doses of GWI-related chemicals, pyridostigmine bromide, N,N-diethyl-m-toluamide (DEET) and permethrin, and 5-minutes of restraint stress for 28 days. Animals were next randomly assigned to two groups, which received daily CUR or vehicle treatment for 30 days. Animals also received 5'-bromodeoxyuridine during the last seven days of treatment for analysis of neurogenesis. Behavioral studies through object location, novel object recognition and novelty suppressed feeding tests performed sixty days after treatment revealed better cognitive and mood function in CUR treated GWI rats. These rats also displayed enhanced neurogenesis and diminished inflammation typified by reduced astrocyte hypertrophy and activated microglia in the hippocampus. Additional studies showed that CUR treatment to GWI rats enhanced the expression of antioxidant genes and normalized the expression of multiple genes related to mitochondrial respiration. Thus, CUR therapy is efficacious for maintaining better memory and mood function in a model of GWI. Enhanced neurogenesis, restrained inflammation and oxidative stress with normalized mitochondrial respiration may underlie better memory and mood function mediated by CUR treatment.

Indexed as

AffectAnimalsAnti-Inflammatory Agents, Non-SteroidalCognitionCurcuminDEETDisease Models, AnimalHippocampusInflammationMaleMitochondriaNeurogenesisOxidative StressPermethrinPersian Gulf SyndromeRatsAnti-Inflammatory Agents, Non-SteroidalCurcuminDEETPermethrinCurcuminGulf War IllnessHippocampal neurogenesisMemory impairmentMitochondriaMood dysfunctionNeuroinflammationOxidative stressReactive oxygen species

Identifiers

PMID29454881
PMCPMC7023905
OpenAlexW2790007567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.